[1] |
FANG Zhie, LI Chengxian, BAI Zhaofang, ZHAO Xu, WANG Jiabo, XIAO Xiaohe.
Investigation of objectivity in the relationship between aristolochic acid and hepatocellular carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 20-24.
|
[2] |
WANG Zhao, ZHAO Jianfeng, YU Xinlan, JIN Hongyu, MA Shuangcheng.
Radiation screening of Chaihu Shugan pills via photostimulated luminescence
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 514-518.
|
[3] |
CAI Yuluo, GUO Jiahui, Wang Xinguo, TIAN Yilong, WANG Meng, NIU Liying, LI Junshan.
Research progress in Yi medicine Valeriana jatamans and predictive analysis of related quality markers
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 348-352.
|
[4] |
HAO Gang, HAN Feng, ZHOU Gang, YAN Hao, WU Xing, LI Xuyang, HOU Hailing, NING Xiao, WANG Qi, CUI Li.
Research on the related substances of adenosine cobalt amine for injection based on HPLC-QE-MS technology
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1339-1345.
|
[5] |
HAO Gang, HAN Feng, ZHOU Gang, WU Xing, YAN Hao, LI Xuyang, HOU Hailing, NING Xiao, CUI Li.
Methodological study of adenosylcobalamin bacterial endotoxin examination for injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1351-1356.
|
[6] |
WANG Zhao, LIU Yue, ZAN Ke, LI Hailiang, JIN Hongyu, MA Shuangcheng.
Preliminary study on extraction technology of tea extract used for Xinnaojian preparation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1362-1367.
|
[7] |
TAN Liyuan, CAI Tong, WANG Yan.
Research progress in quantitative analysis methods for chemical reference substances
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1209-1216.
|
[8] |
LIU Bo, GUO Yunxiao, LIU Lisha, FAN Huihong.
Research progress in key technologies for quality control of snake venom hemocoagulase drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1195-1200.
|
[9] |
HUANG Lu, LIU Bo, WANG Yan, FAN Huihong, ZHANG Qingsheng.
Research progress in quality control of nucleoside antiviral drugs
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 692-696.
|
[10] |
ZHU Xueyan.
Research and Application Progress of Two-dimentional Liquid Chromatography on Quality Control for Traditional Chinese Herbal Medicines
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 643-646.
|
[11] |
YANG Juanyan, YANG Fangrong, YANG Shuang, DAI Jiansong, YANG Ling, BAO Gang.
Application of QCC in Improving Monitoring of ADR Reports in a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 412-417.
|
[12] |
LIU Lei, ZHANG Qiongling, WANG Jiyong, DING Shilan, YOU Yun, XIAO Suping.
Bioassay on Aquatic Extract of Processed Radix Aconiti Carmichaeli
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 75-80.
|
[13] |
ZHANG Qiongling, XIAO Suping, LIU Lei, ZHANG Quan, DING Shilan, YAN Huijie, WANG Jiyong, YOU Yun.
Biological Evaluation for Quality Control of Water Soluble Extracts of Radix Glycyrrhizae Based on Macrophage Phagocytosis Model
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 659-664.
|
[14] |
LIU Kaili, LIANG Jingwei, WANG San, LI Zuojing, YAN Xinli, MENG Fanhao.
Study on the Quantitative Structure-genetic Toxicity Relationships of Pyrrolizidine Alkaloids
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 321-324.
|
[15] |
ZENG Ling, PAN Xiayun.
Analysis of Adverse Event Records in Quality Control of Drug Clinical Trial Institutions
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 693-695.
|